GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals are ahead.
From
To
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health risks; buy from trusted sources.
Scientists have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s disease.
The findings show music therapy could be used as an alternative to drugs.
ADHD Advisor examines why ADHD often goes undiagnosed in women and girls, and how gender biases in symptoms and diagnosis continue to shape outcomes.
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.
Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.
GoodRx reveals just how inadequate and restrictive prescription insurance coverage has become.
GoodRx reveals that while most women spend less than $50 a month on menopause-related treatments, cost remains a major barrier, leading some to delay care or forgo treatment altogether.
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make the process of switching from a compounded GLP-1 to a brand-name GLP-1 smoother, safer, and more affordable.